SCHEMBL31428675

SCHEMBL31428675

CCOC(=O)c1ccc2nc(C)cc(-c3ccc(-c4ccccc4)cc3)c2c1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 3/20 0.56
RAB9A P51151 3/20 0.56
MEN1 O00255 2/20 0.52
KMT2A Q03164 2/20 0.52
ALDH1A1 P00352 3/20 0.51
L3MBTL1 Q9Y468 2/20 0.51
GBA1 P04062 1/20 0.51
MAPT P10636 2/20 0.51
TP53 P04637 1/20 0.51
PDE2A O00408 1/20 0.50
CYP1A2 P05177 2/20 0.49
KDM4E B2RXH2 1/20 0.49
GAA P10253 1/20 0.49
MAPK1 P28482 1/20 0.49
CYP2C9 P11712 1/20 0.49
CYP2C19 P33261 1/20 0.49
TUBB4A P04350 1/20 0.49
TUBB P07437 1/20 0.49
TUBA3C P0DPH7 1/20 0.49
TUBA1B P68363 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24975803 1.00 NPC1 (0.56) NPC1RAB9AMEN1KMT2AALDH1A1
SCHEMBL31428851 0.93 NPC1 (0.54) NPC1RAB9AMEN1KMT2AALDH1A1
SCHEMBL24975644 0.93 NPC1 (0.54) NPC1RAB9AMEN1KMT2AALDH1A1
SCHEMBL31428599 0.92 NPC1 (0.55) NPC1RAB9AMEN1KMT2AALDH1A1
SCHEMBL31428448 0.90 MAPT (0.51) NPC1RAB9AMEN1KMT2AALDH1A1
SCHEMBL24975796 0.90 MAPT (0.51) NPC1RAB9AMEN1KMT2AALDH1A1
SCHEMBL31428992 0.84 IP6K1 (0.53) NPC1RAB9AMEN1KMT2AALDH1A1
SCHEMBL24975485 0.84 ABCG2 (0.47) NPC1MEN1KMT2AALDH1A1L3MBTL1
SCHEMBL31428518 0.84 ABCG2 (0.47) NPC1MEN1KMT2AALDH1A1L3MBTL1
SCHEMBL24975633 0.84 ALDH1A1 (0.50) NPC1RAB9AMEN1KMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250091994-A1 RAS/RAF BINDING INHIBITOR COMPOUND NATIONAL UNIVERSITY CORPORATION KOBE UNIVERSITY (JP) 2025-03-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250091994-A1 RAS/RAF BINDING INHIBITOR COMPOUND BRAF, RAF1, NRAS NPC1 3237/4885RAB9A 67/4885MEN1 1712/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.